…
Cet article regroupe les références bibliographiques des articles suivants:
Thyroïde Traitement pour le meilleur soin de Hashimoto (1/2) : cette première partie aborde l’ensemble des diagnostics à réaliser pour pouvoir déterminer quel traitement sera le plus approprié pour le traitement de la thyroïdite de Hashimoto.
Thyroide Traitement pour le meilleur soin de Hashimoto (2/2) : cette deuxième partie de l’article évoque le choix des traitements allopathiques à proprement parler et des solutions de traitement naturelles complémentaires.
[1] DIAGNOSTIC DE LA THYROIDITE DE HASHIMOTO : LE DOSAGE DES AC ANTI-TPO PLUS FIABLE QUE L’ECHOGRAPHIE – Laboratoire Vialle
[2] Rotondi M, de Martinis L, Coperchini F, Pignatti P, Pirali B, Ghilotti S, Fonte R, Magri F, Chiovato L. Serum negative autoimmune thyroiditis displays a milder clinical picture compared with classic Hashimoto’s thyroiditis. Eur J Endocrinol. 2014 Jul;171(1):31-6. doi: 10.1530/EJE-14-0147. Epub 2014 Apr 17. PMID: 24743395.
[3] Manetti L, Lupi I, Morselli LL, Albertini S, Cosottini M, Grasso L, Genovesi M, Pinna G, Mariotti S, Bogazzi F, Bartalena L, Martino E. Prevalence and functional significance of antipituitary antibodies in patients with autoimmune and non-autoimmune thyroid diseases. J Clin Endocrinol Metab. 2007 Jun;92(6):2176-81. doi: 10.1210/jc.2006-2748. Epub 2007 Mar 6. PMID: 17341554.
[4] Cellini Miriam, Santaguida Maria Giulia, Virili Camilla, Capriello Silvia, Brusca Nunzia, Gargano Lucilla, Centanni Marco- Hashimoto’s Thyroiditis and Autoimmune Gastritis – Frontiers in Endocrinology – VOLUME 8, 2017- DOI=10.3389/fendo.2017.00092 – ISSN=1664-2392
[5] Soumya D. Chakravarty, Joseph A. Markenson, – Chapter 122 – Arthritis Accompanying Endocrine and Metabolic Disorders,
Editor(s): Gary S. Firestein, Ralph C. Budd, Sherine E. Gabriel, Iain B. McInnes, James R. O’Dell, Kelley and Firestein’s Textbook of Rheumatology (Tenth Edition), Elsevier, 2017, Pages 2037-2047.e3, – ISBN 9780323316965, https://doi.org/10.1016/B978-0-323-31696-5.00122-4.
[6] Bektas Uysal, H. and Ayhan, M. (2016), Autoimmunity affects health-related quality of life in patients with Hashimoto’s thyroiditis. The Kaohsiung Journal of Medical Sciences, 32: 427-433. https://doi.org/10.1016/j.kjms.2016.06.006
[7] Karsten Müssig, Andreas Künle, Anna-Laura Säuberlich, Claudia Weinert, Thomas Ethofer, Ralf Saur, Klein, Hans-Ulrich Häring, Stefan Klingberg, Baptist Gallwitz, Thomas Leyhe – Thyroid peroxidase antibody positivity is associated with symptomatic distress in patients with Hashimoto’s thyroiditis, Brain, Behavior, and Immunity, Volume 26, Issue 4, 2012, Pages 559-563, ISSN 0889-1591,- https://doi.org/10.1016/j.bbi.2012.01.006.
[8] Nan Wang, Yan Sun, Hao Yang, Yongxia Xu, Yaojun Cai, Tiantian Liu, Qin Xia, Defa Zhu, and Fen Wang. – Hashimoto’s Thyroiditis Induces Hippocampus-Dependent Cognitive Alterations by Impairing Astrocytes in Euthyroid Mice Nan Wang, Yan Sun, Hao Yang, Yongxia Xu, Yaojun Cai, Tiantian Liu, Qin Xia, Defa Zhu, and Fen Wang – Thyroid.Mar 2021.482-493 – http://doi.org/10.1089/thy.2020.0139
[9] Lata K, Dutta P, Sridhar S, Rohilla M, Srinivasan A, Prashad GR, Shah VN, Bhansali A. Thyroid autoimmunity and obstetric outcomes in women with recurrent miscarriage: a case-control study. Endocr Connect. 2013 Jun 22;2(2):118-24. doi: 10.1530/EC-13-0012. PMID: 23802061; PMCID: PMC3691574.
[10] Meena A, Nagar P. Pregnancy Outcome in Euthyroid Women with Anti-Thyroid Peroxidase Antibodies. J Obstet Gynaecol India. 2016;66(3):160-165. doi:10.1007/s13224-014-0657-6
[11] Meena M, Chopra S, Jain V, Aggarwal N. The Effect of Anti-Thyroid Peroxidase Antibodies on Pregnancy Outcomes in Euthyroid Women. J Clin Diagn Res. 2016;10(9):QC04-QC07. doi:10.7860/JCDR/2016/19009.8403
[12] Maladie de Hashimoto et thyroïdite lymphocytaire – Dans le document Dysendocrinies thyroïdiennes et pancréatiques auto-immunes du chien et du chat : intérêts en pathologie comparée : mise au point bibliographique (Page 95-98)
[13] Moon JH, Hyun MK, Lee JY, et al. Prevalence of thyroid nodules and their associated clinical parameters: a large-scale, multicenter-based health checkup study. Korean J Intern Med. 2018;33(4):753-762. doi:10.3904/kjim.2015.273
[14] Nathalie Silva de Morais, Jessica Stuart, Haixia Guan, Zhihong Wang, Edmund S Cibas, Mary C Frates, Carol B Benson, Nancy L Cho, Mathew A Nehs, Caroline A Alexander, Ellen Marqusee, Mathew I Kim, Jochen H Lorch, Justine A Barletta, Trevor E Angell, Erik K Alexander, The Impact of Hashimoto Thyroiditis on Thyroid Nodule Cytology and Risk of Thyroid Cancer, Journal of the Endocrine Society, Volume 3, Issue 4, April 2019, Pages 791–800, https://doi.org/10.1210/js.2018-00427
[15] Nabhan ZM, Kreher NC, Eugster EA. Hashitoxicosis in children: clinical features and natural history. J Pediatr. 2005 Apr;146(4):533-6. doi: 10.1016/j.jpeds.2004.10.070. PMID: 15812459.
[16] Igor A Harsch, Eckhart G Hahn, Deike Strobel – Hashitoxicosis – Three Cases and a Review of the Literature – November 17th 2011 European Endocrinology, 2008; 4:70-72; DOI: http://doi.org/10.17925/EE.2008.04.00.70
[17] Shahbaz A, Aziz K, Umair M, Sachmechi I. Prolonged Duration of Hashitoxicosis in a Patient with Hashimoto’s Thyroiditis: A Case Report and Review of Literature. Cureus. 2018;10(6):e2804. Published 2018 Jun 14. doi:10.7759/cureus.2804
[18] Brian S. Morris, MD – Hashitoxicosis: An Uncommon Presentation of Autoimmune Thyroid Disease – Proceedings of UCLA Healthcare – VOLUME 17 (2013)
[19] Layal Chaker, Antonio C Bianco, Jacqueline Jonklaas, Robin P Peeters — Hypothyroidism- The Lancet – Published:March 20, 2017 DOI: https://doi.org/10.1016/S0140-6736(17)30703-1
[20] Helmreich DL, Parfitt DB, Lu XY, Akil H, Watson SJ. Relation between the hypothalamic-pituitary-thyroid (HPT) axis and the hypothalamic-pituitary-adrenal (HPA) axis during repeated stress. Neuroendocrinology. 2005;81(3):183-92. doi: 10.1159/000087001. Epub 2005 Jul 11. PMID: 16020927.
[21] Wellwood C, Rardin S. Adrenal and Thyroid Supplementation Outperforms Nutritional Supplementation and Medications for Autoimmune Thyroiditis. Integr Med (Encinitas). 2014;13(3):41-47.
[22] S. Melmed, Chapter 15 – Hypothalamic–Pituitary Regulation, Editor(s): P. Michael Conn, Conn’s Translational Neuroscience, Academic Press, 2017, Pages 317-331, ISBN 9780128023815, https://doi.org/10.1016/B978-0-12-802381-5.00025-7.
[23] Shahbaz A, Aziz K, Umair M, Sachmechi I. Prolonged Duration of Hashitoxicosis in a Patient with Hashimoto’s Thyroiditis: A Case Report and Review of Literature. Cureus. 2018;10(6):e2804. Published 2018 Jun 14. doi:10.7759/cureus.2804
[24] ??
[25] Majumder A, Sanyal D. A case of simultaneous occurrence of Graves’ disease and Hashimoto’s thyroiditis. Indian J Endocrinol Metab. 2012;16(Suppl 2):S338-S339. doi:10.4103/2230-8210.104082
[26] Xu S, Huang H, Qian J, Liu Y, Huang Y, Wang X, Liu S, Xu Z, Liu J. Prevalence of Hashimoto Thyroiditis in Adults With Papillary Thyroid Cancer and Its Association With Cancer Recurrence and Outcomes. JAMA Netw Open. 2021 Jul 1;4(7):e2118526. doi: 10.1001/jamanetworkopen.2021.18526. PMID: 34313737; PMCID: PMC8317012.
[27] Feldt-Rasmussen U. Hashimoto’s thyroiditis as a risk factor for thyroid cancer. Curr Opin Endocrinol Diabetes Obes. 2020 Oct;27(5):364-371. doi: 10.1097/MED.0000000000000570. PMID: 32773575.
[28] ??
[29] Belfiore A, La Rosa GL, La Porta GA, Giuffrida D, Milazzo G, Lupo L, Regalbuto C, Vigneri R. Cancer risk in patients with cold thyroid nodules: relevance of iodine intake, sex, age, and multinodularity. Am J Med. 1992 Oct;93(4):363-9. doi: 10.1016/0002-9343(92)90164-7. PMID: 1415299.
[30]
[31]
[32]
[1] Shmuely H, Shimon I, Gitter LA. Helicobacter pylori infection in women with Hashimoto thyroiditis: A case-control study. Medicine (Baltimore). 2016 Jul;95(29):e4074. doi: 10.1097/MD.0000000000004074. PMID: 27442635; PMCID: PMC5265752.
[2] Rajič B, Arapović J, Raguž K, Bošković M, Babić SM, Maslać S. Eradication of Blastocystis hominis prevents the development of symptomatic Hashimoto’s thyroiditis: a case report. J Infect Dev Ctries. 2015 Jul 30;9(7):788-91. doi: 10.3855/jidc.4851. PMID: 26230132.